Research Article

The effect of Glycyrrhiza glabra extracts on inhibiton of 3Clpro

Volume: 63 Number: 2 June 10, 2024
EN TR

The effect of Glycyrrhiza glabra extracts on inhibiton of 3Clpro

Abstract

The Sars-CoV-2 virus causes the COVID-19 disease, which is characterized by high mortality rate and symptoms such as severe acute respiratory failure. However, it has been proven that the 3-chymotrypsin-like protease (3Clpro) enzyme, which plays a key role in the replication of the Sars-CoV-2 virus, can be inhibited by certain natural compounds with a flavonoid structure. Flavonoids interact with the active site of the enzyme, resulting in enzyme inhibition. In this project, the aim was to determine the inhibitory concentrations of flavonoid molecules on 3Clpro and obtain the most effective extracts of licorice root (Glycyrrhiza Glabra L.), which is known to contain high levels of these molecules. The goal of our project is to investigate the effects of extracts obtained from licorice root using different extraction methods on the inhibition of the 3Clpro enzyme and their potential role in the treatment of Sars-CoV-2 virus infection. In our study, the phenolic content of these natural products was determined for the first time using LC MS/MS, and the inhibitory effect of these natural product extracts on the 3Clpro enzyme was also studied for the first time. When licorice root extracts were evaluated in terms of antioxidant parameters, the highest TEAC, FRAP, and DPPH levels were observed particularly in ethanol extracts. The extracts that showed the highest inhibition effect for the 3-CLpro enzyme of licorice root were respectively obtained by soaking at 80°C for 6 hours, soaking in an ultrasound bath for 20 minutes, soaking in water at 40°C for 24 hours, soaking in 60% ethanol, and soaking in 80% ethanol. The most studied bioactive compounds of licorice root in the literature are glycyrrhizin, glycyrrhetinic acid, isoliquiritin, and isoflavones. However, in this study, the phenolic acid and flavonoid content, which are not widely covered in the literature, were also examined. Among the compounds studied in licorice root, the most abundant compounds were found to be apigenin, pelargonin, cyanidin, maleic acid, ethyl ferulate, and chlorogenic acid

Keywords

Supporting Institution

Ege Üniversitesi Rektörlüğü BAP koordinatörlüğü

Project Number

22077

Thanks

Projeyi destekleyen (TSG-2020-22077) Ege Üniversitesi Rektörlüğü BAP birimine ve bitki ekstrelerini sağlayan dr. Henri Phytopharma firmasına teşekkür ederiz.

References

  1. Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020 Apr 30;382(18):1708–20.
  2. Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S, et al. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine. 2022 Apr 1;98:153930.
  3. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar 1;19(3):141–54.
  4. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun 1;46(6):1099–102.
  5. Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-ldrissi M, Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J Biomol Struct Dyn. 2021;39(8):2971–9.
  6. Omer SE, Ibrahim TM, Krar OA, Ali AM, Makki AA, Ibraheem W, et al. Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations. Biochem Biophys Rep. 2022 Mar 1;29.
  7. dos Santos CN, Menezes R, Stewart D. Polyphenols as New Leads in Drug Discovery: Biological Activity and Mechanisms. Curr Pharm Des. 2018 Sep 26;24(19):2041–2.
  8. Ali S, Alam M, Khatoon F, Fatima U, Elasbali AM, Adnan M, et al. Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights. Biomedicine & Pharmacotherapy. 2022 Mar 1;147:112658.

Details

Primary Language

English

Subjects

Medical Biochemistry and Metabolomics (Other)

Journal Section

Research Article

Publication Date

June 10, 2024

Submission Date

September 14, 2023

Acceptance Date

December 29, 2023

Published in Issue

Year 1970 Volume: 63 Number: 2

Vancouver
1.Erhan Canbay, Meltem Kocamanoğlu, Cemrehan Fedacı, Öznur Çopur, Murat Ünlü, Yasemin Akçay, Eser Y. Sözmen. The effect of Glycyrrhiza glabra extracts on inhibiton of 3Clpro. EJM. 2024 Jun. 1;63(2):271-8. doi:10.19161/etd.1358629

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.